The majority of treatment in the United States has historically focused on an abstinence-based treatment model; however, as evidenced by increased acceptance of the medical-based treatment model, harm-reduction therapy is gaining popularity and credibility nationwide. Medication Assisted Treatment (MAT) has been practiced for decades, to include known drugs/medications such as Antabuse and Methadone. Opioid treatment is also commonly referred to as Opioid Treatment Programs (OTP). Clients with co-occurring disorders being prescribed psychotropic medication have also been identified as receiving MAT services. As science and technology continues to advance, newer and more effective medications have evolved. These include drugs such as Suboxone, Naltrexone, and Acamprosate, all FDA approved, which are specific in treating substance-abuse based disorders.
Suboxone is a drug/medication only through prescription. This drug is comprised of a combination of two drugs: Buprenorphine and Naloxone. It is classified as a partial opiate agonist. Suboxone became FDA approved in 2002 and is commonly used to treat opiate addiction, which can include illicit drugs like heroin and/or opiate-based pain reduction medication like Vicodin. Suboxone is also designed to reduce cravings for opiate-based drugs. Like all medications, Suboxone has known side-effects, and patients must be closely monitored through the stabilization period, usually consisting of the first 30-days. The side-effects are known to be less severe than its counterpart Methadone and a patient is not in need of the medication for a long duration. Typically, a patient will participate in a 12-month Suboxone program and the dosage includes titration.
As with any medication prescribed for addiction and/or mental health purposes, our agency does not believe that these medications serve as a replacement for traditional therapy. We support Suboxone medication being used in conjunction with traditional therapy, as statistics support greater success rates, reduced relapse, and increased long-term sobriety. Our two agencies embrace harm-reduction therapy as a catalyst towards ultimately helping clients achieve long-term sobriety.
Our agency is proud to offer Suboxone services. For those who are new to Suboxone services and/or medication, the first step is to contact our agency and schedule a medical exam appointment with our doctor. The exam appointment is a comprehensive session to evaluate medical status, collect history, and learn more about your relationship with opiates. Following this appointment, individuals will participate in an Induction. All our inductions are in-house. You will then meet with the doctor regularly and be written a prescription for your Suboxone medication. Our Suboxone program is designed to be a 12 to 24-month titration program. We do not discriminate on the origin of the opiate abuse and work with all types of opiate abuse. Our agency also accepts transfers seeking continued Suboxone services. Please call us today to learn more about Suboxone medication or our Suboxone program. We are here to help